Published in
Taylor and Francis Group, Leukemia & Lymphoma, 6(60), p. 1576-1579, 2018
DOI: 10.1080/10428194.2018.1542147
Links
Tools
Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group
Journal article published in 2018 by
Antonio Rueda,
Virginia Calvo,
María Casanova,
Delvys Rodriguez-Abreu,
David Aguiar,
Marta Llanos,
Ruth Alvarez,
Natividad Martinez-Banaclocha,
Jesús Alfaro,
Cristina Quero,
Ana Blasco,
Luis de la Cruz Merino,
Joaquín Herrero,
Francisco R. García-Arroyo,
Mariano Provencio 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 